VEXIM, a medical device company specializing in the minimally-invasive treatment of vertebral fractures, has announced that the results of a new comparative biomechanical study carried out by Marburg University’s Traumatology Department (Germany) have been published in The Spine Journal.
As in the first biomechanical study published (results disclosed on September 12th, 2013), the aim of this new study was to evaluate the anatomic restoration of 24 fractured vertebral bodies with osteoporosis by comparing the SpineJack® and balloon kyphoplasty techniques. The results once again demonstrated a significant difference in favor of the SpineJack® regarding the restoration of vertebral height that is achieved to reestablish spinal balance.
“The central vertebral height restoration was close to 96% for the groups treated with SpineJack®. The clinical implications include better restoration of the sagittal balance of the spine and a reduction of the kyphotic deformity”, said Dr. Antonio Krüger, Orthopedic Trauma surgeon in trauma and reconstructive surgery at the Philipp’s University (Marburg) and the study’s main investigator.
The article, entitled “Height restoration of osteoporotic vertebral compression fractures using different intravertebral reduction devices: a cadaveric study”, is available online.
Vincent Gardès, CEO of VEXIM, concludes: “We are proud of the publication of Dr. Krüger’s new study in such a prestigious clinical and scientific review as The Spine Journal, and would like to congratulate his team for their in-depth scientific work. The results of our biomechanical studies, combined with those announced recently on two other clinical studies, clearly show the efficiency of the SpineJack® and reinforce our confidence in our ability to establish it as a benchmark for the treatment of vertebral compression fractures.”
These vertebral fractures stand for 1.4 million new cases every year in Europe1 and 700,000 in the United States2.